hypercholesterolaemia. Pure hypercholesterolemia
Conditions
Interventions
Intervention 1: intervention group(natsa4) : 500 mg natsa capsule 3 times a day.before breakfast, after lunch and after dinner. Intervention 2: Placebo Group(natsa6): natsa capsul 500mg 3 times a day.
Treatment - Drugs
intervention group(natsa4) : 500 mg natsa capsule 3 times a day.before breakfast, after lunch and after dinner.
Placebo Group(natsa6): natsa capsul 500mg 3 times a day.before breakfast and after midday and after dinner.
Sponsors
Tehran, Research Institute for Islamic and Complementary Medicine, Tehran university of Medical Sci
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion critries: 194 < ch<348 or 200<tg<400 and 194 < ch<348, Age range 18 to 60 years, Not improvement or control of disease by diet. Exclusion critries:History of early cardio vascular evevnt, At the admission use any of these drugs:(Cortico Steroid, Androgenic, Ocp, Phenytoin or Lipid reduction drugs), pregnancy, lactating, alcohlic, Drug abuse, History of liver diseaese ,History of renal disease, History of alergy to herbal drugs, refusal to continue the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum cholesterol level. Timepoint: Before intervention, 2 weeks after intervention,4 weeks after intervention, 6 weeks after intervention. Method of measurement: bio chemistry- laboratory.;Serum low density lipoprotein level. Timepoint: Before intervention, 2 weeks after intervention,4 weeks after intervention, 6 weeks after intervention. Method of measurement: biochemistry- laboratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum level of Alanine transaminase. Timepoint: Before intervention, 2 weeks after intervention,4 weeks after intervention, 6 weeks after intervention. Method of measurement: bio chemistry- laboratory.;Serum level of Aspartate aminotransferase. Timepoint: Before intervention, 2 weeks after intervention,4 weeks after intervention, 6 weeks after intervention. Method of measurement: biochemistry- laboratory.;Serum level of Creatinine. Timepoint: Before intervention, 2 weeks after intervention,4 weeks after intervention, 6 weeks after intervention. Method of measurement: biochemistry- laboratory.;Serum level of Urea. Timepoint: Before intervention, 2 weeks after intervention,4 weeks after intervention, 6 weeks after intervention. Method of measurement: biochemistry- laboratory.;Platelet count. Timepoint: Before intervention, 2 weeks after intervention,4 weeks after intervention, 6 weeks after intervention. Method of measurement: biochemistry- laboratory.;Serum level of Alkaline Phosphatase. Timepoint: Before intervention, 2 weeks after intervention,4 weeks after intervention, 6 weeks after intervention. Method of measurement: biochemistry- laboratory.;Weight. Timepoint: Before intervention, 2 weeks after intervention,4 weeks after intervention, 6 weeks after intervention. Method of measurement: numeral.;Complete Blood Count. Timepoint: Before intervention, 2 weeks after intervention,4 weeks after intervention, 6 weeks after intervention. Method of measurement: biochemistry- laboratory.;Serum level of Triglyceride. Timepoint: Before intervention, 2 weeks after intervention,4 weeks after intervention, 6 weeks after intervention. Method of measurement: Bio chemistry- laboratory.;Serum level of High Density Lipo protein(HDL). Timepoint: Before intervention, 2 weeks after intervention,4 weeks after intervention, 6 weeks after intervention. Method of measurement: Biochemistry- laboratory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Majid Emtiazy
Tehran University of Medical Science, Traditional Medicine faculty
Outcome results
None listed